RAINBOW - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.8

🏥 RAINBOW shows strong fundamentals and institutional support, but weak momentum and valuation risks suggest a cautious intraday setup.

📈 Positive

• 📈 ROCE of 18.3% and ROE of 16.7% reflect strong operational and financial efficiency.
• 📈 Quarterly PAT stable at ₹51.7 Cr. with 33.5% YoY growth, showing earnings consistency.
• 📈 DII holding increased by 2.02%, indicating strong domestic institutional confidence.
• 📈 Volume of 2.64 lakh is above 1-week average of 1.40 lakh, showing rising intraday interest.
• 📈 Price near DMA 50 (₹1,400) and DMA 200 (₹1,423) may act as resistance-turned-support if breached.

⚠️ Limitation

• 📉 MACD at -3.91 and RSI at 55.2 indicate neutral momentum with limited upside.
• 📉 P/E of 56.5 vs. industry P/E of 57.2 suggests fair but stretched valuation.
• 📉 PEG ratio of 3.17 signals expensive valuation relative to growth.
• 📉 Price down ~19% from 52-week high, showing long-term resistance.

🚫 Company Negative News

• 📉 FII holding declined by 1.75%, showing foreign investor caution.

✅ Company Positive News

• 🏥 Strong performance in pediatric and maternity care segments continues to drive revenue growth.
• 📢 Expansion into Tier-2 cities and digital health initiatives support long-term scalability.

🏭 Industry

• 🩺 Industry P/E of 57.2 reflects high growth expectations in healthcare and specialty hospitals.
• 📈 Sector supported by rising demand for quality care and insurance penetration.

📌 Conclusion

• ⚠️ RAINBOW is a moderate intraday candidate with strong fundamentals but weak momentum and valuation risks.
• 💡 Consider buying near ₹1,385–₹1,391 with target at ₹1,405–₹1,415 and stop-loss at ₹1,375.
• 📤 If already holding, exit if price crosses ₹1,412 with volume > 2.8 lakh or RSI > 60.

I can also chart RAINBOW’s intraday resistance zones and volume spikes to help refine your trade setup.